Aura Biosciences (AURA) Prepaid Assets (2020 - 2026)
Aura Biosciences' (AURA) quarterly Prepaid Assets came in at $3.8 million in Q1 2026, up 112.81% YoY from $1.8 million in Q1 2025, and up 126.35% on a QoQ basis from $1.7 million in Q4 2025.
Aura Biosciences (AURA) Prepaid Assets (2020 - 2026) Analysis & Trends
Aura Biosciences (AURA) has 7 years of Prepaid Assets data on file, last reported at $3.8 million in Q1 2026.
- Quarterly Prepaid Assets rose 112.81% year-over-year to $3.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.8 million (up 112.81% YoY) and the FY2025 annual result came in at $1.7 million, down 82.52% from the prior year.
- Prepaid Assets rose to $3.8 million in Q1 2026, from $1.7 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $9.5 million in Q4 2024 to a low of $306000.0 in Q3 2022.
- A 5-year average of $3.7 million and a median of $2.6 million in 2025 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2024 — Prepaid Assets jumped 958.2% — and 2025, when it sank 82.52%.
- Tracing AURA's Prepaid Assets over 5 years: stood at $2.2 million in 2022, then advanced by 10.81% to $2.4 million in 2023, then jumped by 295.56% to $9.5 million in 2024, then slumped by 82.52% to $1.7 million in 2025, then surged by 126.35% to $3.8 million in 2026.
- The last three Prepaid Assets figures came in at $3.8 million (Q1 2026), $1.7 million (Q4 2025), and $2.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Aura Biosciences | 797.49 Mn | 729.65 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.19 Mn |
| Mar 31, 2026 | 3.77 Mn |
| Dec 31, 2025 | 1.67 Mn |
| Sep 30, 2025 | 2.59 Mn |
| Jun 30, 2025 | 2.62 Mn |
| Mar 31, 2025 | 1.77 Mn |
| Dec 31, 2024 | 9.53 Mn |
| Sep 30, 2024 | 3.42 Mn |
| Jun 30, 2024 | 8.18 Mn |
| Mar 31, 2024 | 9.38 Mn |
| Dec 31, 2023 | 2.41 Mn |
| Sep 30, 2023 | 323,000.00 |
| Jun 30, 2023 | 988,000.00 |
| Mar 31, 2023 | 1.52 Mn |
| Dec 31, 2022 | 2.17 Mn |
| Sep 30, 2022 | 306,000.00 |
| Jun 30, 2022 | 5.51 Mn |
| Mar 31, 2022 | 6.28 Mn |
| Dec 31, 2021 | 4.62 Mn |
| Sep 30, 2021 | 80,000.00 |